Elisa Fabbrini1, Caterina Conte, Faidon Magkos. 1. Center for Human Nutrition, Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St. Louis, MO 63110, USA. efabbrini@dom.wustl.edu
Abstract
PURPOSE OF REVIEW: Intrahepatic fat content is increasingly being recognized as an integral part of metabolic dysfunction. This article reviews available methods for the assessment of hepatic steatosis. RECENT FINDINGS: Apart from liver biopsy, there are several noninvasive radiologic modalities for evaluating nonalcoholic fatty liver disease. Ultrasonography, computed tomography, and traditional MRI remain largely qualitative methods for detecting mild to severe degrees of steatosis rather than quantitative methods for measuring liver fat content, even though novel attempts to collect objective quantitative information have recently been developed. Still, their sensitivity at mild degrees of steatosis is poor. Undoubtedly, most methodological advances have occurred in the field of MRI and magnetic resonance spectroscopy, which currently enable the accurate quantification of intrahepatic fat even at normal or near normal levels. Xenon computed tomography was also recently shown to offer another objective tool for the quantitative assessment of steatosis, although more validation studies are required. SUMMARY: Several modalities can be used for measuring intrahepatic fat and assessing steatosis; the choice will ultimately depend on the intended use and available resources.
PURPOSE OF REVIEW: Intrahepatic fat content is increasingly being recognized as an integral part of metabolic dysfunction. This article reviews available methods for the assessment of hepatic steatosis. RECENT FINDINGS: Apart from liver biopsy, there are several noninvasive radiologic modalities for evaluating nonalcoholic fatty liver disease. Ultrasonography, computed tomography, and traditional MRI remain largely qualitative methods for detecting mild to severe degrees of steatosis rather than quantitative methods for measuring liver fat content, even though novel attempts to collect objective quantitative information have recently been developed. Still, their sensitivity at mild degrees of steatosis is poor. Undoubtedly, most methodological advances have occurred in the field of MRI and magnetic resonance spectroscopy, which currently enable the accurate quantification of intrahepatic fat even at normal or near normal levels. Xenon computed tomography was also recently shown to offer another objective tool for the quantitative assessment of steatosis, although more validation studies are required. SUMMARY: Several modalities can be used for measuring intrahepatic fat and assessing steatosis; the choice will ultimately depend on the intended use and available resources.
Authors: Jennifer L Rehm; Ellen L Connor; Peter M Wolfgram; Jens C Eickhoff; Scott B Reeder; David B Allen Journal: J Pediatr Date: 2014-05-22 Impact factor: 4.406
Authors: Sun Choon Song; Seong Ho Choi; Dong Wook Choi; Jin Seok Heo; Woo Seok Kim; Min Jung Kim Journal: World J Gastroenterol Date: 2011-08-28 Impact factor: 5.742
Authors: Jennifer L Rehm; Peter M Wolfgram; Diego Hernando; Jens C Eickhoff; David B Allen; Scott B Reeder Journal: Eur Radiol Date: 2015-04-28 Impact factor: 5.315
Authors: Rachel M Williamson; Jackie F Price; Stephen Glancy; Elisa Perry; Lisa D Nee; Peter C Hayes; Brian M Frier; Liesbeth A F Van Look; Geoffrey I Johnston; Rebecca M Reynolds; Mark W J Strachan Journal: Diabetes Care Date: 2011-04-08 Impact factor: 19.112
Authors: Subhash Kamath; Alberto O Chavez; Amalia Gastaldelli; Francesca Casiraghi; Glenn A Halff; Gregory A Abrahamian; Alberto M Davalli; Raul A Bastarrachea; Anthony G Comuzzie; Rodolfo Guardado-Mendoza; Lilia M Jimenez-Ceja; Vicki Mattern; Ana Maria Paez; Andrea Ricotti; Mary E Tejero; Paul B Higgins; Iram Pablo Rodriguez-Sanchez; Devjit Tripathy; Ralph A DeFronzo; Edward J Dick; Gary W Cline; Franco Folli Journal: PLoS One Date: 2011-11-18 Impact factor: 3.240